Literature DB >> 34246448

Limitations and Pitfalls of FDG-PET/CT in Infection and Inflammation.

Jordy P Pijl1, Pieter H Nienhuis1, Thomas C Kwee1, Andor W J M Glaudemans1, Riemer H J A Slart2, Lars C Gormsen3.   

Abstract

White blood cells activated by either a pathogen or as part of a systemic inflammatory disease are characterized by high energy consumption and are therefore taking up the glucose analogue PET tracer FDG avidly. It is therefore not surprising that a steadily growing body of research and clinical reports now supports the use of FDG PET/CT to diagnose a wide range of patients with non-oncological diseases. However, using FDG PET/CT in patients with infectious or inflammatory diseases has some limitations and potential pitfalls that are not necessarily as pronounced in oncology FDG PET/CT. Some of these limitations are of a general nature and related to the laborious acquisition of PET images in patients that are often acutely ill, whereas others are more disease-specific and related to the particular metabolism in some of the organs most commonly affected by infections or inflammatory disease. Both inflammatory and infectious diseases are characterized by a more diffuse and less pathognomonic pattern of FDG uptake than oncology FDG PET/CT and the affected organs also typically have some physiological FDG uptake. In addition, patients referred to PET/CT with suspected infection or inflammation are rarely treatment naïve and may have received varying doses of antibiotics, corticosteroids or other immune-modulating drugs at the time of their examination. Combined, this results in a higher rate of false positive FDG findings and also in some cases a lower sensitivity to detect active disease. In this review, we therefore discuss the limitations and pitfalls of FDG PET/CT to diagnose infections and inflammation taking these issues into consideration. Our review encompasses the most commonly encountered inflammatory and infectious diseases in head and neck, in the cardiovascular system, in the abdominal organs and in the musculoskeletal system. Finally, new developments in the field of PET/CT that may help overcome some of these limitations are briefly highlighted.
Copyright © 2021 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 34246448     DOI: 10.1053/j.semnuclmed.2021.06.008

Source DB:  PubMed          Journal:  Semin Nucl Med        ISSN: 0001-2998            Impact factor:   4.446


  7 in total

1.  Tumor glycolytic heterogeneity improves detection of regional nodal metastasis in patients with lung adenocarcinoma.

Authors:  Kun-Han Lue; Sung-Chao Chu; Ling-Yi Wang; Yen-Chang Chen; Ming-Hsun Li; Bee-Song Chang; Sheng-Chieh Chan; Yu-Hung Chen; Chih-Bin Lin; Shu-Hsin Liu
Journal:  Ann Nucl Med       Date:  2021-11-24       Impact factor: 2.668

2.  Challenging Results on FDG PET/CT in a Patient with Uncontrolled Celiac Disease and small bowel adenocarcinoma.

Authors:  Ali Mohamedkhair; Akram Al-Ibraheem; Ahmed Saad Abdlkadir; Omar Jaber
Journal:  Asia Ocean J Nucl Med Biol       Date:  2022

3.  Evaluation of an ImmunoPET Tracer for IL-12 in a Preclinical Model of Inflammatory Immune Responses.

Authors:  Nerissa T Viola; James E Glassbrook; Jhansi R Kalluri; Justin B Hackett; Madison N Wicker; Joshua Sternberg; Heather M Gibson
Journal:  Front Immunol       Date:  2022-05-11       Impact factor: 8.786

Review 4.  Novel PET Imaging of Inflammatory Targets and Cells for the Diagnosis and Monitoring of Giant Cell Arteritis and Polymyalgia Rheumatica.

Authors:  Kornelis S M van der Geest; Maria Sandovici; Pieter H Nienhuis; Riemer H J A Slart; Peter Heeringa; Elisabeth Brouwer; William F Jiemy
Journal:  Front Med (Lausanne)       Date:  2022-06-06

5.  Brain Inflammation and Intracellular α-Synuclein Aggregates in Macaques after SARS-CoV-2 Infection.

Authors:  Ingrid H C H M Philippens; Kinga P Böszörményi; Jacqueline A M Wubben; Zahra C Fagrouch; Nikki van Driel; Amber Q Mayenburg; Diana Lozovagia; Eva Roos; Bernadette Schurink; Marianna Bugiani; Ronald E Bontrop; Jinte Middeldorp; Willy M Bogers; Lioe-Fee de Geus-Oei; Jan A M Langermans; Ernst J Verschoor; Marieke A Stammes; Babs E Verstrepen
Journal:  Viruses       Date:  2022-04-08       Impact factor: 5.818

6.  Comparison of 68Ga-DOTANOC and 18F-FDG PET-CT Scans in the Evaluation of Primary Tumors and Lymph Node Metastasis in Patients With Rectal Neuroendocrine Tumors.

Authors:  Zhihao Zhou; Zhixiong Wang; Bing Zhang; Yanzhang Wu; Guanghua Li; Zhao Wang
Journal:  Front Endocrinol (Lausanne)       Date:  2021-09-01       Impact factor: 5.555

7.  Disease severity and status in Stevens-Johnson syndrome and toxic epidermal necrolysis: Key knowledge gaps and research needs.

Authors:  Rannakoe J Lehloenya
Journal:  Front Med (Lausanne)       Date:  2022-09-12
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.